```html

Lupus Erythematosus – A Complete Medical Guide

Overview

Lupus erythematosus (commonly called “lupus”) is a chronic, systemic autoimmune disease in which the body’s immune system attacks its own tissues. The most common form is Systemic Lupus Erythematosus (SLE), but lupus can also be limited to the skin (discoid lupus), kidneys (lupus nephritis), or other organs.

Lupus can affect anyone, but it is most prevalent among women of child‑bearing age (15‑44 years). In the United States, an estimated 1.5 million adults have lupus, with a prevalence of about 20–150 cases per 100,000 people, depending on ethnicity and geography.<sup>[1][2]</sup> It is three to four times more common in African‑American, Hispanic, Asian, and Native American populations compared with Caucasians.

Symptoms

Lupus is notorious for its “great imitator” reputation because its signs can mimic many other conditions. Symptoms often fluctuate, with periods of flare‑ups and remission.

General / Constitutional

• Fatigue – persistent, not relieved by rest.
• Fever – low‑grade (often <100.4°F / 38°C) without infection.
• Weight loss – unintended, may accompany gastrointestinal involvement.
• Night sweats.

Cutaneous (Skin)

• Butterfly rash (malar rash) – red, raised rash across the cheeks and bridge of the nose, sparing the nasolabial folds.
• Discoid lesions – round, scaly patches that can scar.
• Photosensitivity – rash or worsening of existing lesions after sun exposure.
• Subacute cutaneous lupus – red, ring‑shaped lesions on arms, torso, or sun‑exposed areas.
• Oral or nasal ulcers – painless or mildly painful sores.

Musculoskeletal

• Arthritis – non‑erosive, affecting small joints of hands and wrists.
• Myalgia – muscle aches without true inflammation.

Renal

• Lupus nephritis – swelling of the face/legs, foamy urine, hypertension, or reduced kidney function.

Cardiopulmonary

• Pleural effusion – chest pain that worsens with breathing.
• Pericarditis – sharp chest pain relieved by leaning forward.
• Pulmonary hypertension – shortness of breath, fatigue.

Neurological

• Headaches or migraines.
• Seizures or psychosis (rare).
• Cognitive dysfunction (“lupus fog”).

Hematologic

• Anemia, leukopenia, or thrombocytopenia (low blood counts).

Gastrointestinal

• Nausea, vomiting, abdominal pain – can be related to vasculitis or medication side‑effects.

Causes and Risk Factors

The exact cause of lupus remains unknown, but it is believed to result from a complex interaction of genetic, hormonal, environmental, and immunologic factors.

Genetic predisposition

• More than 50 loci (genes) have been linked to SLE, including HLA‑DR2 and HLA‑DR3 alleles.<sup>[3]</sup>
• First‑degree relatives have a 5–10 % higher risk compared with the general population.

Hormonal influences

• Estrogen appears to augment immune response; disease onset often coincides with puberty, pregnancy, or oral contraceptive use.

Environmental triggers

• Ultraviolet (UV) radiation – sunlight can precipitate skin lesions and systemic flares.
• Infections – especially Epstein‑Barr virus (EBV) and hepatitis C.
• Medications – drug‑induced lupus (e.g., hydralazine, procainamide, isoniazid) typically resolves after stopping the drug.
• Smoking – doubles the risk of developing lupus and worsens disease activity.

Other risk factors

• Female sex (≈90 % of cases).
• Age 15–44 years.
• Certain ethnicities (African‑American, Hispanic, Asian, Native American).
• Family history of autoimmune disease.

Diagnosis

Lupus diagnosis is primarily clinical, supported by laboratory testing. No single test confirms the disease.

Classification criteria

The American College of Rheumatology (ACR) and the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR) criteria require a combination of clinical features and a positive ANA (antinuclear antibody) test, weighted by a point system. A score ≥10 points fulfills the classification for SLE.

Key laboratory tests

• Antinuclear antibody (ANA) – most sensitive (≈95 % positivity) but not specific.
• Anti‑double‑stranded DNA (anti‑dsDNA) – highly specific; levels often correlate with renal disease activity.
• Anti‑Smith (anti‑Sm) antibodies – highly specific but present in only ~30 % of patients.
• Complement levels (C3, C4) – low during active disease.
• Complete blood count (CBC) – looks for anemia, leukopenia, thrombocytopenia.
• Urinalysis – proteinuria, cellular casts suggest lupus nephritis.
• Kidney biopsy – gold standard for classifying lupus nephritis (Class I–VI).

Imaging and other studies

• Chest X‑ray or CT for pleural/pericardial effusions.
• Echocardiogram for pericarditis or Libman‑Sacks endocarditis.
• MRI/CT brain if neurologic symptoms are present.

Treatment Options

Therapy is individualized, aiming to control inflammation, prevent organ damage, and minimize drug toxicity.

First‑line medications

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – for mild joint pain or serositis.
• Antimalarials (hydroxychloroquine) – cornerstone for skin and joint disease; reduces flares and improves survival.<sup>[4]</sup>
• Corticosteroids – prednisone or prednisolone, dose‑adjusted to disease severity. Use the lowest effective dose to limit long‑term side effects.

Immunosuppressive agents

• Azathioprine – for maintenance therapy and steroid‑sparing.
• Mycophenolate mofetil (MMF) – preferred for moderate‑to‑severe lupus nephritis.
• Methotrexate – useful for arthritis and skin disease.
• Cyclophosphamide – reserved for severe organ involvement (renal, CNS).

Targeted biologic therapies

• Belimumab – monoclonal antibody against B‑lymphocyte stimulator (BLyS); approved for active, autoantibody‑positive SLE.
• Rituximab – anti‑CD20 B‑cell depleting agent; used off‑label for refractory disease.

Adjunctive treatments

• Anticoagulation – for patients with antiphospholipid antibody syndrome.
• Calcium & vitamin D supplementation – to counteract steroid‑induced bone loss.
• Vaccinations – annual influenza, pneumococcal, HPV; avoid live vaccines while on high‑dose immunosuppression.

Lifestyle & self‑management

• Sun protection: broad‑spectrum SPF ≥ 30, protective clothing, and UV‑blocking sunglasses.
• Regular low‑impact exercise (e.g., swimming, walking) to maintain cardiovascular health and joint flexibility.
• Balanced diet rich in omega‑3 fatty acids, antioxidants, and adequate protein.
• Stress‑reduction techniques (mindfulness, yoga, counseling).
• Smoking cessation – dramatically improves response to treatment.

Living with Lupus erythematosus

Adapting daily life to manage lupus can improve quality of life and reduce flare frequency.

Medication adherence

• Use pill organizers or smartphone reminders.
• Keep a medication list and share it with every healthcare provider.

Monitoring disease activity

• Track symptoms in a journal (rash, fatigue, joint pain, urine changes).
• Regular rheumatology visits every 3–6 months, or sooner during flares.
• Perform home urine dip‑tests if instructed by your doctor to detect early nephritis.

Work and school

• Request reasonable accommodations (flexible hours, rest periods, ergonomic workstation).
• Educate teachers or supervisors about the condition to foster understanding.

Emotional health

• Join support groups (e.g., Lupus Foundation of America).
• Consider cognitive‑behavioral therapy for anxiety or depression, which affect up to 30 % of patients.<sup>[5]</sup>

Family planning

• Pregnancy is possible but requires careful planning; disease should be quiescent for at least 6 months.
• Continue hydroxychloroquine (safe in pregnancy) and adjust other meds under specialist guidance.
• Discuss contraception options; avoid estrogen‑containing pills if active disease.

Prevention

Because lupus cannot be completely prevented, strategies focus on reducing triggers and minimizing disease activity.

• Sun protection – the single most effective measure to prevent cutaneous flares.
• Smoking cessation – lowers risk of severe disease and cardiovascular events.
• Vaccination – prevents infections that could precipitate a flare.
• Regular medical follow‑up – early detection of organ involvement allows prompt treatment.
• Healthy lifestyle – balanced diet, adequate sleep, and regular exercise.

Complications

If lupus is inadequately controlled, it can lead to serious, sometimes life‑threatening complications.

• Lupus nephritis – may progress to end‑stage renal disease requiring dialysis or transplant.
• Cardiovascular disease – accelerated atherosclerosis, myocardial infarction, stroke.
• Neuropsychiatric lupus – seizures, psychosis, cognitive decline.
• Pulmonary hypertension – right‑heart failure.
• Infections – immunosuppressive therapy predisposes to bacterial, viral, and fungal infections.
• Osteoporosis – chronic steroid use.
• Pregnancy loss – higher rates of miscarriage, pre‑eclampsia, and preterm birth.

When to Seek Emergency Care

```